CDNCancerTrials Profile Banner
CCTG Profile
CCTG

@CDNCancerTrials

Followers
2K
Following
6K
Media
778
Statuses
4K

The Canadian Cancer Trials Group is a cancer clinical trials research cooperative that runs phase I-III trials to test anti-cancer and supportive therapies.

Kingston, Ontario
Joined January 2017
Don't wanna be here? Send us removal request.
@CDNCancerTrials
CCTG
19 hours
#CCTG is currently seeking applications for a Patient Representative for the Gastrointestinal Disease Site Committee. CCTG is an inclusive organization, dedicated to building a diverse network where the patient voice is integral to our research agenda. https://t.co/XnnYDyrEtY
0
0
0
@CDNCancerTrials
CCTG
8 days
A special Seminar with Dr Jean Desy where he discusses working on the North Shore of Quebec, in Cree country and among the Inuit of Nunavik for 47 years. Teaching literature and medicine at the Faculty of Medicine at Laval University for 23 years https://t.co/Zjug5HKJok
0
0
0
@CDNCancerTrials
CCTG
12 days
Results from the primary analysis of the ctDNA-negative cohort of the international DYNAMIC-III (CO29) colon cancer trial were presented at the #ESMO25 Presidential Symposium #bccancer #PeterMacCallumCancerCentre #canadiancancersociety #GiCancerInstitute https://t.co/aL2CWSbRLi
0
0
2
@Thalcin
Thierry Alcindor, MD, MSc
12 days
Great seeing everybody! Always nice to catch up.
@GillSharlene
Sharlene Gill, MD, MPH, MBA, FASCO
13 days
#ESMO25 Day 3 The GI poster session was buzzing and for good reason! @CathyEngMD @FLordick28391 @Thalcin @myESMO #ESMOAmbassadors
0
1
4
@CDNCancerTrials
CCTG
12 days
Dr Glenwood Goss presents the #CCTG #BR31 study final overall survival and minimal residual disease analyses today at #ESMO25. The trial tested whether there is a benefit to receiving adjuvant immunotherapy after tumour resection in early-stage non-small cell lung cancer.
0
0
2
@DoctorJSpicer
Jonathan Spicer MD PhD
12 days
Adjuvant IO with OS benefit guided by proof of molecular residual disease? Now that makes good Canadian sense! Congrats @CDNCancerTrials!!!
0
5
55
@urotoday
UroToday.com
12 days
TRIPLE-SWITCH trial tests docetaxel addition for #mHSPC patients with suboptimal PSA response. @sokolova_md @OHSUKnight joins @AndreaMiyahira @PCFnews to discuss this newly activated SWOG/CCTG study addressing treatment intensification in metastatic hormone-sensitive prostate
0
4
10
@DrNeilGross
Neil D. Gross, MD, FACS
12 days
So great to be back at @myESMO to present our trial-in-progress @NRGonc #HN014 testing neoadjuvant #immunotherapy in advanced, resectable #skin #CSCC cancer @Regeneron @CDNCancerTrials @TROGfightcancer #OncSurgery @MDAndersonNews #ESMO2025
0
7
22
@CDNCancerTrials
CCTG
12 days
Dr Booth presenting the #CCTG #CO21 #CHALLENGE trial to the GI tumours group at #ESMO2025 - the study was recently published in #NEJM https://t.co/xd2WKbvlP2
0
2
4
@JiaJennyLiu
Jia (Jenny) Liu MD PhD
21 days
Delighted to join @CDNCancerTrials IND 🍂meeting to share “Innovations From Down Under” 🇦🇺🦘 in early phase trials including: 🌟collaborative consortia @NECTANSW 🌟decentralised trials 🌟equity thru CALD partnerships 🌟novel proteomic biomarkers for ADCs @CMRI_AUS
0
2
3
@TDorffOnc
Tanya Dorff
1 month
Another important trial launched in ⁦@CDNCancerTrials⁩ & ⁦@SWOG⁩ for #prostatecancer - TripleSwitch will ask whether early docetaxel chemo can improve survival when doublet hormone therapy not working well enough. PR26 led by Dr Ong and Dr Sokolova
1
9
23
@GillSharlene
Sharlene Gill, MD, MPH, MBA, FASCO
14 days
Excited to be at the #ESMO25 launch of the phase 3 @CDNCancerTrials 🇨🇦 #BATTMAN CO.33 BOT/BAL vs BSC in refractory MSS mCRC #unmetneed #trialsthatmatter Congrats to @jonathanloree 🙌 @ocall0 @Agenus_Bio @GICancer @JeanneTie Let’s get this done! 🇨🇦 🇦🇺 🇫🇷 @coloncanada
3
16
59
@CDNCancerTrials
CCTG
22 days
The #CCTG Pharmacy Network needs pharmacy representation for the Pharmacy Network Steering Group and the Pharmacy Network Disease Site. Find out more and how to apply > https://t.co/3pcCCf27HD
0
1
1
@CDNCancerTrials
CCTG
23 days
#BreastCancerAwarenessMonth - The #CCTG MAC30 trial is testing adding chemotherapy to the usual treatment of ovarian function suppression plus hormonal therapy in premenopausal ER-positive/HER2-negative patients who are at high risk of cancer returning https://t.co/K6fzpzZspu
0
0
0
@CDNCancerTrials
CCTG
24 days
The Q3 2025 listing of #CCTG trials in development is now live. Find out what trials will be made available soon and which trials have been recently activated > https://t.co/O7wPrFifpk
0
0
0
@CDNCancerTrials
CCTG
25 days
The Canadian Cancer Trials Group #CCTG is currently seeking applications for a Patient Representative to support the #Gastrointestinal Disease Site Committee. Find out more > https://t.co/lBwdk2BdIM
0
0
0
@CDNCancerTrials
CCTG
26 days
October is #LiverCancerAwarenessMonth and the #CCTG HE2 trial researchers want to know if the combination of three common drugs used to treat #livercancer can offer better results than the standard treatment. https://t.co/HzIj3eLn3B
0
1
1
@CDNCancerTrials
CCTG
29 days
Come join the #CCTG team - apply today for the position of Human Resources and Staffing Operations Leader, responsible for a range of Human Resources and Staffing activities in support of the administration and operation of the group. https://t.co/Gs8o6qcN0U
0
0
0
@OncologyBGLab
BG Lab
1 month
@oncology_bg collaborated with @CDNCancerTrials to publish a paper in @JNCI_Now about baseline financial difficulty among patients participating in clinical trials and its association with mortality.
academic.oup.com
AbstractBackground. The incidence and worsening of financial difficulty among patients with cancer participating in clinical trials and their relationship
1
3
6
@DrNeilGross
Neil D. Gross, MD, FACS
1 month
Another great month of accrual to @NRGonc #HN014 #C-PRE for patients with advanced, resectable #skin #CSCC cancer. Excited for 🇦🇺 and 🇨🇦 to join the fight!🚀 @NCICancerCtrl @TROGfightcancer @CDNCancerTrials @Regeneron #OncSurgery @MDAndersonNews
0
6
18